ClinicalTrials.Veeva

Menu

Study Comparing Two Different Tablet Formulations Of Bosutinib Under Fed Conditions

Wyeth logo

Wyeth

Status and phase

Completed
Phase 1

Conditions

Healthy

Treatments

Drug: SKI-606 (Bosutinib)

Study type

Interventional

Funder types

Industry

Identifiers

NCT01080365
3160A4-1120
B1871016

Details and patient eligibility

About

Study comparing 2 formulations of bosutinib in healthy subjects.

Enrollment

31 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men or women of nonchildbearing potential age 18 to 50 years

Exclusion criteria

  • Any clinically significant medical condition

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

31 participants in 2 patient groups

1
Experimental group
Description:
Commercial Tablet
Treatment:
Drug: SKI-606 (Bosutinib)
Drug: SKI-606 (Bosutinib)
2
Experimental group
Description:
Clinical Tablet
Treatment:
Drug: SKI-606 (Bosutinib)
Drug: SKI-606 (Bosutinib)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems